(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM
- CAS No.
- 7361-76-4
- Chemical Name:
- (+)-PENTAZOCINE - DEA SCHEDULE IV ITEM
- Synonyms
- Pentazozine;(2S,6S,11S)-;d-Pentazocine;(+)-cis-Pentazocine;(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM;(11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol;(11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocine-8-ol;(2S,11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol;[2S,6S,11S,(+)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocine-8-ol;2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2S,6S,11S)- (9CI)
- CBNumber:
- CB1504116
- Molecular Formula:
- C19H27NO
- Molecular Weight:
- 285.43
- MDL Number:
- MOL File:
- 7361-76-4.mol
Last updated:2023-04-23 13:52:06
Boiling point | 403.5±45.0 °C(Predicted) |
---|---|
Density | 1.036±0.06 g/cm3(Predicted) |
pka | 10.10±0.60(Predicted) |
form | solid |
color | white |
optical activity | [α]23/D +134.6°, c = 1 in chloroform(lit.) |
FDA UNII | A2G9VU2P2J |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302+H312+H332 |
Precautionary statements | P261-P264-P280-P301+P312-P302+P352+P312-P304+P340+P312 |
Hazard Codes | Xn |
Risk Statements | 20/21/22 |
Safety Statements | 36 |
WGK Germany | 3 |
(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM Preparation Products And Raw materials
Raw materials
Preparation Products
(+)-PENTAZOCINE - DEA SCHEDULE IV ITEM
(11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol
(11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocine-8-ol
(2S,11S)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2β,6β-methano-3-benzazocin-8-ol
[2S,6S,11S,(+)]-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocine-8-ol
d-Pentazocine
(2S,6S,11S)-
Pentazozine
2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2S,6S,11S)- (9CI)
(+)-cis-Pentazocine
7361-76-4
Agonists
Opioids
Pharmacologicals
Chiral Reagents
Heterocycles
Intermediates & Fine Chemicals
Pharmaceuticals